After a meal, some people experience high spikes in blood sugar followed by crashing lows. This can cause fatigue, anxiety ...

Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX ...

Abbott's mixed reality technology helps distract blood donors and reduce their anxiety levels. This can help encourage young ...

ABT stock surges 21.7% year to date on CGM sales growth and robust diagnostics demand, even as FX and macro risks weigh on forecasts.

The global continuous glucose monitoring device market is estimated to be valued at USD 12,690.7 million in 2025 and is projected to reach USD 54,553.1 million by 2035, registering a CAGR of 15.7% ...

An all-inclusive approach to diabetes management becomes key—one that includes staying active indoors, eating mindfully, and keeping up with glucose monitoring ... CGM devices like FreeStyle Libre ...

The healthcare sector is an ideal place for long-term investors to focus their attention, in my view. You won't need a ...

The American Diabetes Association, now endorses automated insulin delivery (AID) systems as the leading approach for ...

The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...

Abbott Laboratories flexes its market muscle with consistent gains and an enviable track record of long-term growth. Its ...

Beta Bionics, Inc. BBNX recently entered into a strategic agreement with Abbott Laboratories ABT to integrate its iLet Bionic ...

Tandem Diabetes Care has announced that the Tandem t:slimX2 insulin pump with Control-IQ+ automated insulin delivery (AID) technology now works with Abbott’s FreeStyle Libre 3 Plus continuous glucose ...